rs727504288
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM4_SupportingPP5_Strong
The NM_000256.3(MYBPC3):c.2441_2443del(p.Lys814del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.0000372 in 1,613,360 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. K814K) has been classified as Likely benign.
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000038 ( 0 hom. )
Consequence
MYBPC3
NM_000256.3 inframe_deletion
NM_000256.3 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.70
Genes affected
MYBPC3 (HGNC:7551): (myosin binding protein C3) MYBPC3 encodes the cardiac isoform of myosin-binding protein C. Myosin-binding protein C is a myosin-associated protein found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. MYBPC3 is expressed exclusively in heart muscle and is a key regulator of cardiac contraction. Mutations in this gene are a frequent cause of familial hypertrophic cardiomyopathy. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
PM1
?
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 12 uncertain in NM_000256.3
PM4
?
Nonframeshift variant in NON repetitive region in NM_000256.3. Strenght limited to Supporting due to length of the change: 1aa.
PP5
?
Variant 11-47337549-CTCT-C is Pathogenic according to our data. Variant chr11-47337549-CTCT-C is described in ClinVar as [Uncertain_significance]. Clinvar id is 177700.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=11, Likely_pathogenic=2}. Variant chr11-47337549-CTCT-C is described in Lovd as [Pathogenic]. Variant chr11-47337549-CTCT-C is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYBPC3 | NM_000256.3 | c.2441_2443del | p.Lys814del | inframe_deletion | 25/35 | ENST00000545968.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.2441_2443del | p.Lys814del | inframe_deletion | 25/35 | 5 | NM_000256.3 | P4 | |
MYBPC3 | ENST00000399249.6 | c.2441_2443del | p.Lys814del | inframe_deletion | 24/34 | 5 | A2 | ||
MYBPC3 | ENST00000544791.1 | c.2414-41_2414-39del | intron_variant, NMD_transcript_variant | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.0000263 AC: 4AN: 152162Hom.: 0 Cov.: 31
GnomAD3 genomes
?
AF:
AC:
4
AN:
152162
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1461198Hom.: 0 AF XY: 0.0000440 AC XY: 32AN XY: 726856
GnomAD4 exome
AF:
AC:
56
AN:
1461198
Hom.:
AF XY:
AC XY:
32
AN XY:
726856
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0000263 AC: 4AN: 152162Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74324
GnomAD4 genome
?
AF:
AC:
4
AN:
152162
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
74324
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Pathogenic:3Uncertain:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hypertrophic cardiomyopathy 4 Pathogenic:2Uncertain:2
Likely pathogenic, flagged submission | clinical testing | Laboratory of Genetics and Molecular Cardiology, University of São Paulo | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | 3billion | Jan 03, 2022 | This inframe deletion in the non-repeat region can change the length of the protein and disrupt protein function (PM4_M).The variant is located in a well-established functional domain or exonic hotspot, where pathogenic variants have frequently reported (PM1_M). The variant has been reported at least twice as pathogenic/likely pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000177700, PMID:12110947). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000061, PM2_M). Therefore, this variant is classified as uncertain significance according to the recommendation of ACMG/AMP guideline. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Feb 14, 2019 | This variant was classified as: Uncertain significance. The available evidence favors the pathogenic nature of this variant, however the currently available data is insufficient to conclusively support its pathogenic nature. Thus this variant is classified as Uncertain significance - favor pathogenic. The following ACMG criteria were applied in classifying this variant: PM1,PM4. - |
Likely pathogenic, no assertion criteria provided | clinical testing | Cardiology unit, Meyer University Hospital | Sep 27, 2022 | The c.2441_2443del in MYBPC3 is an inframe deletion that has been reported in multiple patients with Hypertrophic Cardiomyopathy (Jaaskelainen et al J Mol Med (Berl) 2002; Kim et al J Clin Med 2020; Bagnall et al Circ Genom Precis Med 2022; Field et al J Med Genet 2022). The variant has been reported in GnomAD with an extremely low frequency (MAF 0.006%) but metrics indicate poor data quality. It is located in a well established functional domain or exonic hotspot, where pathogenic variants have frequently reported. The c.2441_2443del co-segregates with Hypertrophic Cardiomyopathy for three meiosis (internal laboratory data). ClinVar and HGMD Professional databases contains an entry for this variation (Variation ID 177700 and CD021840). Even if one study has shown that this variant does not substantially affect MYBPC3 stability (Bahrudin U et al J Mol Biol 2008), these results are insufficient to demonstrated the normal function of the protein. In conclusion, according to the recommendation of ACMG/AMP guideline, the c.2441_2443del is classified as likely pathogenic (PM4_M; PM1_M; PM2_S; PP1_S) - |
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 05, 2021 | An in vitro functional study of this variant showed normal protein levels when expressed in COS-7 cells, and the variant did not destabilize the protein through the ubiquitin-proteasome system as was shown for another MYBPC3 variant (Bahrudin et al., 2008), however, any other aspects of cardiac myosin-binding protein C function were not assessed; Reported in ClinVar as a variant of uncertain significance by several laboratories (ClinVar Variant ID# 177700; Landrum et al., 2016); In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 16715312, 16566405, 21415409, 15563892, 21499742, 23054336, 12110947, 33297573, 20800588, 20474083, 18929575, 15114369, 25524337, 26688388, 15519027, 18957093, 24111713, 28518168, 26084686, 24093860, 23674513, 31513939, 31737537, 32492895, 33148509) - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2022 | MYBPC3: PM1, PM2, PM4:Supporting, BS3:Supporting - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 09, 2023 | The p.Lys814del variant in MYBPC3 has been identified in at least 20 individuals with HCM and segregated with disease in 2 affected relatives from 2 families. It has also been identified in 1 individual with DCM (Jääskeläinen 2002 PMID: 12110947, Van Driest 2004 PMID: 15519027, Andersen 2004 PMID: 15114369, Cardim 2005 PMID: 16566405, Song 2005 PMID: 15563892, Zeller 2006 PMID: 16715312, Bahrudin 2008 PMID: 18929575, Ehlermann 2008 PMID: 18957093, Marsiglia 2013 PMID: 24093860, Berge 2014 PMID: 24111713, Akinrinade 2015 PMID: 26084686, Rupp 2019 PMID: 30105547, Marschall 2019 PMID: 31737537, Micheu 2020 PMID: 33297573, Robyns 2020 PMID: 31513939, Kim 2020 PMID: 32492895, LMM data). This variant has also been reported by other clinical laboratories in ClinVar (Variation ID #177700) and has been identified in 0.016% (4/24882) of Finnish chromosomes by gnomAD (https://gnomad.broadinstitute.org, v.3.1.2) and. This variant is a deletion of 1 lysine (Lys) residue at position 814 from a stretch of 4 lysines. It is unclear if this deletion will impact protein function. An in vitro study did not demonstrate an impact on protein function (Bahurdin 2008 PMID: 18929575). In summary, the clinical significance of the p.Lys814del variant is uncertain. ACMG/AMP Criteria applied: PS4_supporting, BS3_Supporting. - |
Hypertrophic cardiomyopathy Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Dec 20, 2023 | This variant, c.2441_2443del, results in the deletion of 1 amino acid(s) of the MYBPC3 protein (p.Lys814del), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has been observed in individual(s) with MYBPC3-related conditions (PMID: 12110947, 15519027, 15563892, 16566405, 16715312, 18929575, 18957093, 23674513, 24093860, 24111713, 26084686, 31513939, 31737537, 33297573, 33407484, 35208637). This variant is also known as K811del. ClinVar contains an entry for this variant (Variation ID: 177700). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant does not substantially affect MYBPC3 function (PMID: 18929575). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Likely pathogenic, flagged submission | clinical testing | Center for Human Genetics, University of Leuven | Oct 31, 2018 | - - |
Cardiomyopathy Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Mar 30, 2023 | This variant causes a deletion of one lysine residue from 4 consecutive lysine residues present in codons 811-814 of the MYBPC3 protein. A functional study has shown that this variant does not have adverse effects on protein expression levels or stability (PMID: 18929575). This variant has been reported in individuals affected with hypertrophic cardiomyopathy (PMID: 15519027, 18929575, 23674513, 23711808, 24111713, 33297573), left atrial enlargement (PMID: 33407484), dilated cardiomyopathy (PMID: 26084686), or sudden death (PMID: 26688388, 36588553). This variant has been identified in 17/279948 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Jun 01, 2021 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 27, 2023 | Variant summary: MYBPC3 c.2441_2443delAGA (p.Lys814del) results in an in-frame deletion that is predicted to remove one amino acid from the fibronectin type III domain (IPR003961) of the encoded protein. The variant allele was found at a frequency of 3.7e-05 in 1614122 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in MYBPC3 causing Cardiomyopathy (3.7e-05 vs 0.001), allowing no conclusion about variant significance. c.2441_2443delAGA has been reported in the literature in multiple individuals affected with Hypertrophic Cardiomyopathy without strong evidence for causality, and has been reported in several unaffected relatives (e.g. Jaaskelainen_2002, Micheu_2019). This variant has also been reported in one individual with Dilated Cardiomyopathy (Akinrinade_2015) and in a cohort of individuals with unspecified Cardiomyopathies (Stava_2023). These reports do not allow any conclusions about variant significance. At least one publication reports experimental evidence evaluating an impact on protein function. These results showed no damaging effect of this variant on mRNA or protein expression, or 20S proteasome activity in vitro (Bahrudin_2008). The following publications have been ascertained in the context of this evaluation (PMID: 26084686, 15114369, 18929575, 24111713, 16566405, 32380161, 18957093, 34400558, 24888384, 12110947, 24093860, 23054336, 31513939, 15563892, 35653365, 15519027, 23674513, 16715312, DOI: 10.25083/rbl/24.1/91.99). Twelve submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Ten submitters classified the variant as uncertain significance and two classified it as likely pathogenic. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Primary familial hypertrophic cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Blueprint Genetics | Feb 11, 2015 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2023 | The c.2441_2443delAGA variant (also known as p.K814del) is located in coding exon 25 of the MYBPC3 gene. This variant results from an in-frame AGA deletion at nucleotide positions 2441 to 2443. This results in the in-frame deletion of a lysine at codon 814, removing one of the lysines in a four-lysine tract. This variant has been reported in individuals with pediatric onset hypertrophic cardiomyopathy (Maron BJ et al. Am J Cardiol, 2015 Feb;115:402-4; Rupp S et al. Clin Res Cardiol, 2019 Mar;108:282-289). This alteration (also reported as p.K811del) has been detected in a number of hypertrophic cardiomyopathy cohorts as well as a dilated cardiomyopathy cohort, but clinical details were frequently limited and some of the probands also had alterations in other cardiac-related genes (e.g., Van Driest SL et al. J. Am. Coll. Cardiol. 2004;44:1903-10; Cardim N et al. Rev Port Cardiol. 2005;24:1463-76; Song L et al. Clin. Chim. Acta. 2005;351:209-16; Zeller R et al. J. Mol. Med. 2006;84:682-91; Ehlermann P et al. BMC Med. Genet. 2008;9:95; Miller EM et al. J Genet Couns. 2013;22:258-67; Berge KE et al. Clin. Genet. 2014;86:355-60; Jääskeläinen P et al. Ann. Med. 2014;46:424-9; Akinrinade O et al. Eur. Heart J. 2015;36:2327-37; Mademont-Soler I et al. PLoS ONE. 2017;12:e0181465). In one study, this alteration did not affect MYBPC3 protein stability; however, protein function was not tested (Bahrudin U et al. J. Mol. Biol. 2008;384:896-907). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al., PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at